We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

BP and Verenium Announce Pivotal Biofuels Agreement


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BP and Verenium Announce Pivotal Biofuels Agreement"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 
BP and Verenium Corporation have announced an agreement for BP Biofuels North America to acquire Verenium's cellulosic biofuels business, including the Company's facilities in Jennings, LA and San Diego, CA for $98.3 million.

Verenium will retain its commercial enzyme business, including its biofuels enzymes products and have the right to develop its own lignocellulosic enzyme program. Verenium will also retain select R&D capabilities, as well as rights to access select biofuels technology developed by BP using the technology it is acquiring from Verenium through this agreement.

"We are very pleased that our strategic development partnership with BP has successfully advanced our cellulosic ethanol technology to the cusp of commercialization," said Carlos A. Riva, President and Chief Executive Officer at Verenium. "We believe that BP is the right company to make the investment needed to carry this forward and expedite the commercialization of the technology."

"This agreement should give both companies the flexibility to pursue the growth opportunities in the respective businesses and achieve goals in the near-term. As a result of this transaction, Verenium will have the resources to grow our commercial enzyme business while maintaining strategic access to the emerging cellulosic ethanol market in a manner that better fits our resources," added Riva.

The major terms of this agreement include:

BP will acquire the following:
• Jennings, LA facilities, including the pilot plant and the demonstration-scale facility as well as the San Diego, CA R&D facilities;
• Cellulosic biofuels technology and related IP; and
• Cellulosic enzyme technology and related IP.
In addition, BP would retain scientists and technologists needed to continue the biofuels development program.
Verenium will retain / receive the following:
• The core commercial enzyme business, including the personnel and supporting technology required to develop the business, including for applications in the biofuels segment;
• $98.3 million payment from BP;
• $10.8 million in cash (currently restricted) to be released upon assignment of its lease for the San Diego facility to BP;
• The ability to access select biofuels products developed by BP using the technology it is acquiring from Verenium; and
• The ability to transition out of the San Diego, CA facility over the next two years.

BP will become the sole investor in Vercipia Biofuels, a 50-50 joint venture formed by BP and Verenium in February 2009, and will independently manage all of Vercipia's activities going forward. Similarly, Galaxy Biofuels, a 50-50 joint development company owned by BP and Verenium, will be owned 100% by BP. This transaction is expected to close in the third quarter of 2010.
Advertisement